Controversies and Criticisms on Designs for Experimental Autoimmune Labyrinthitis

Although immune-mediated inner ear disease was reported around 25 years ago, numerous attempts to identify the inner ear antigens have been performed. Experimental animal models have been used to study the immune mechanisms involved in hearing loss and to develop new therapies. Because animal models of autoimmune labyrinthitis have been developed by means of different antigens, we cannot yet show a valid immunopathologic explanation. A critical analysis of the more relevant experimental models employed has been performed in order to validate the methodology. Comparison between these models and animals with spontaneous systemic autoimmune disease has raised more questions concerning the pathophysiology of autoimmune hearing loss. A new pathogenetic theory is suggested, involving the supporting cells of the organ of Corti.

[1]  A. Trinidad,et al.  Supporting Cells As a Target of Cisplatin‐Induced Inner Ear Damage: Therapeutic Implications , 2004, The Laryngoscope.

[2]  Shunichi Tomiyama.  Experimental autoimmune labyrinthitis , 2003 .

[3]  G. Mogi,et al.  Localization of Glucocorticoid Receptors in the Murine Inner Ear , 2002, The Annals of otology, rhinology, and laryngology.

[4]  S. Tomiyama.  Experimental autoimmune labyrinthitis: assessment of molecular size of autoantigens in fractions of inner ear proteins eluted on the Mini Whole Gel Eluter. , 2002, Acta oto-laryngologica.

[5]  M. Cilli,et al.  Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome , 2002, The Lancet.

[6]  H. Matsuoka,et al.  Induction of Endolymphatic Hydrops by Directly Infused Monoclonal Antibody against Type Ii Collagen CB11 Peptide , 2002, The Annals of otology, rhinology, and laryngology.

[7]  W. Arnold,et al.  Clinical and Experimental Studies of Autoimmune Inner Ear Disease , 2002, Acta oto-laryngologica. Supplementum.

[8]  A. Trinidad,et al.  Actividad citotóxica coclear del cisplatino en animales de experimentación. un estudio con microscopia electrónica de barrido , 2002 .

[9]  D. Trune,et al.  Decreased Cochlear DNA Receptor Staining in MRL.MpJ‐Faslpr Autoimmune Mice With Hearing Loss , 2001, The Laryngoscope.

[10]  E. Keithley,et al.  Characterization of an Experimentally Induced Inner Ear Immune Response , 2000, The Laryngoscope.

[11]  J. G. García Berrocal,et al.  Immune response and immunopathology of the inner ear: an update , 2000, The Journal of Laryngology & Otology.

[12]  S. Ikehara,et al.  T Cells Infiltrating from the Systemic Circulation Proliferate in the Endolymphatic Sac , 1999, The Annals of otology, rhinology, and laryngology.

[13]  M. Ruckenstein,et al.  Strial Dysfunction in the MRL-Faslpr mouse , 1999 .

[14]  D. Trune,et al.  Second Place—Resident Basic Science Award 1998: Steroid-responsive Cochlear Dysfunction in the MRL/lpr Autoimmune Mouse , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[15]  M. Ruckenstein,et al.  Effects of Immunosuppression on the Development of Cochlear Disease in the MRL‐Faslpr Mouse , 1999, The Laryngoscope.

[16]  M. Ruckenstein,et al.  Strial dysfunction in the MRL-Fas mouse. , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[17]  E. Keithley,et al.  Immunohistochemical Analysis of Proliferating Cells in a Sterile Labyrinthitis Animal Model , 1998, The Laryngoscope.

[18]  Y. Kurono,et al.  Changes in Immunostaining of Inner Ears After Antigen Challenge Into the Scala Tympani , 1998, The Laryngoscope.

[19]  Y. Nakai,et al.  Induction of macrophage exudation in the inner ear by OK432 treatment. , 1998, Acta oto-laryngologica. Supplementum.

[20]  David W. Lin,et al.  Breakdown of Stria Vascularis Blood-Labyrinth Barrier in C3H/lpr Autoimmune Disease Mice , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[21]  Masashi Suzuki,et al.  Expression of Intercellular Adhesion Molecule-1 during Inner Ear Inflammation , 1995, The Annals of otology, rhinology, and laryngology.

[22]  E. Keithley,et al.  Development of high endothelial venule‐like characteristics in the spiral modiolar vein induced by viral labyrinthitis , 1993, The Laryngoscope.

[23]  J. Harris,et al.  Spontaneous Remission in Experimental Autoimmune Labyrinthitis , 1992, The Annals of otology, rhinology, and laryngology.

[24]  J. Harris,et al.  Spiral Modiolar Vein: Its Importance in Viral Load of the Inner Ear , 1992, The Annals of otology, rhinology & laryngology. Supplement.

[25]  E. Keithley,et al.  Spiral modiolar vein: its importance in inner ear inflammation. , 1990, Acta oto-laryngologica.

[26]  S. Am.  Type II collagen-induced inner ear disease: critical evaluation of the guinea pig model. , 1990 .

[27]  A. Soliman.  Type II collagen-induced inner ear disease: critical evaluation of the guinea pig model. , 1990, The American journal of otology.

[28]  A. Soliman,et al.  Experimental autoimmune inner ear disease , 1989, The Laryngoscope.

[29]  Mitsuaki Takahashi,et al.  Analysis of immunocompetent cells following inner ear immunostimulation , 1988, The Laryngoscope.

[30]  N. Woolf,et al.  Cochlear pathophysiology associated with inner ear immune responses. , 1986, Acta oto-laryngologica.

[31]  A. Ryan,et al.  A Reexamination of Experimental Type II Collagen Autoimmunity: Middle and Inner Ear Morphology and Function , 1986, The Annals of otology, rhinology, and laryngology.

[32]  A. Kang,et al.  Type II Collagen-Induced Autoimmune Sensorineural Hearing Loss and Vestibular Dysfunction in Rats , 1983, The Annals of otology, rhinology, and laryngology.

[33]  J. Mathews,et al.  AUTOIMMUNE SENSORINEURAL HEARING LOSS , 1980, The Lancet.

[34]  B. Mccabe.  Autoimmune Sensorineural Hearing Loss , 1979, The Annals of otology, rhinology, and laryngology.